Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Cold Chain Distribution

03 Dec 2012 - 04 Dec 2012 - London, UK



Bookmark and Share


The SMi Group Presents their 7th Annual 

Cold Chain Distribution - Europe’s Premier Event

Following the success of last year’s event, the SMi’s Cold Chain Distribution is set to have its best year yet. With leading members of the industry gathering together to discuss, learn and explore the industry, the conference provides a fantastic forum for the most up to date look at cold chain technologies, innovations and management strategies.

This year’s conference will focus on the emerging technologies in the industry, improving the efficiency of the cold chain process, ensuring quality of pharmaceutical products, and the latest in regulations and risk assessments. Perhaps most exciting, is the introduction of 6 new conference sessions, set to give the best opportunities to network, discover and share the latest in the cold chain process.

New for 2012

A Site Visit to the World Courier distribution site: This year you will have the opportunity visit one of World Courier’s biggest sites, situated at Heathrow Airport. You will observe live operations to get a true understanding of the handling of your product throughout its distribution. 

Key Reasons to Attend

Explore the new regulations in cold chain, and how to ensure compliance throughout distribution 

Learn of the hidden regulations in global supply chain, and how to navigate them to ensure compliance

Get Insights into the ways that pharmaceutical companies ensure the safety and effective transportation of pharmaceutical products despite challenges and issues that are faced

See the latest technology innovations in packaging, storage, temperature monitoring and transportation and how they can benefit your company’s supply chain 

Hear about Good Distribution Practices in the industry and how they can be applied to all aspects the cold chain distribution process to create a smooth transition in each stage of transport 

Discuss risk assessments, predictive models, and adaptability of the transport chain to ensure the minimum risk and maximum efficiency of the transport of pharmaceutical goods 

Quote “Technology Network” and save £100

Register online here: http://www.smi-online.co.uk/goto/2012coldchain17.asp



Further information
Scientific News
Human Stem Cells to Rapidly Generate Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
New Mechanism of Tuberculosis Infection
Researchers have identified a new infection mechanism of tuberculosis that could lead to a new therapeutic angle.
Modelling ALS Requires ‘Aged’ Stem Cells
Research suggests engineered cells are too ‘young’ to accurately model ALS and should be 'aged' to speed progress toward finding potential treatments.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Rapid Generation from Stem Cells
Researchers coax human stem cells to rapidly generate bone and heart muscle by directing stem cells down complex developmental pathways.
HIV Hides No Longer
Researchers are working to create proteins that clear HIV-infected cells in order to eliminate latent infection and dormancy.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!